{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-026551","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2022-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.534430+00:00","generated_at":"2026-06-21T04:48:15.683921+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Bolt Biotherapeutics appoints Laura Berner to Board of Directors","bullets":["Board expanded from 9 to 10; Laura Berner appointed as Class I director, term through 2025 annual meeting.","Berner qualifies as independent under Nasdaq rules; no reportable related-party transactions.","Received initial option award for 50,000 shares, vesting over 36 months, and prorated option for 12,261 shares.","Eligible for annual option of 25,000 shares and $35,000 cash retainer under non-employee director compensation policy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-026551","json":"https://secwatch.observer/filing/0000950170-22-026551.json","markdown":"https://secwatch.observer/filing/0000950170-22-026551.md","text":"https://secwatch.observer/filing/0000950170-22-026551.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000095017022026551/0000950170-22-026551-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000095017022026551/bolt-20221214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T04:48:15.683921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51d358f680","claim":"Laura Berner was appointed as Class I Director at Bolt Biotherapeutics, Inc..","evidence_excerpt":"the Board then appointed Laura Berner to the Board as a Class I director of the Company, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017022026551/0000950170-22-026551-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}